Cedars-Sinai planea su primer intento de producir células madre en el espacio y su cuarto lanzamiento de experimentos con células madre a la Estación Espacial Internacional. El lanzamiento, financiado por la NASA, está previsto para el 3 de agosto a las 11 a.m. EDT/8 a.m. PDT.
Tag: Cancer Drugs
A First for Cedars-Sinai’s Fourth Space Launch
Cedars-Sinai is planning its first-ever attempt to produce stem cells in space and its fourth launch of stem cell experiments to the International Space Station. The NASA-funded launch is scheduled for Aug. 3 at 11 a.m. EDT/8 a.m. PDT.
Pharmacologist: Cancer drug shortage is delaying lifesaving treatments
This year, an estimated 2 million Americans will be diagnosed with cancer. Now, a New York Institute of Technology pharmacology expert contends that these patients’ realities could grow increasingly harsher, as a monthslong shortage of chemotherapy drugs continues. Low supplies of…
Cause of heart damage from cancer drugs identified
Safer cancer drugs are now one step closer after a new study led by UCL (University College London) researchers found the likely reason that some treatments damage the heart.
A New Method to Test Cancer Drug Toxicity
A new study from researchers at Cummings School of Veterinary Medicine at Tufts University and Tufts Medical Center reports that heart tissue obtained through organ donations from dogs dying of other causes are a promising platform for testing cancer drug toxicity, offering scientists a new alternative.
Ultrasound activates anticancer agent
An international research team led by Dr. Johannes Karges from the Faculty of Chemistry and Biochemistry at Ruhr University Bochum, Germany, has developed a complex that accumulates in tumour tissue and is activated there by ultrasound waves.
Treating Parasites with Cancer Drugs
Entamoeba histolytica is a parasitic disease affecting up to 50 million people and killing more than 50,000 people each year worldwide. The standard of care is a drug called Metronidazole/Flagyl, but it is far from ideal — therapy requires three…
USC Norris Comprehensive Cancer Center receives $5 million for cancer drug discoveries
USC Norris Comprehensive Cancer Center receives $5 million for cancer drug discoveries
April Edition of SLAS Discovery Now Accessible
April’s edition of SLAS Discovery features the cover article, “Maximizing the Value of Cancer Drug Screening in Multicellular Tumor Spheroid Cultures: A Case Study in Five Head and Neck Squamous Cell Carcinoma Cell Lines.”